Enterprise Dynamic

Jiuzhang Biotech Data Presentation on the Phase I Clinical Trial on the Safety, Tolerability and Pharmacokinetics of Chlorogenic Acid for Injection in Treating Advanced Cerebral Glioma

The Second China BioMed Innovation and Investment Conference was held at the Suzhou Jinjihu International Conference Center on October 29, 2017, on which the Jiuzhang Biotech released the data of phas...

[View details]

Brain glioma patent approved

On July 12, 2017, the Company received the Patent Authorization issued by the State Intellectual Property Bureau, which showed that the Company has obtained one more granted invention patent in treati...

[View details]

Clinical Data Release on Chlorogenic Acid for Injection of Class I New Drugs Worldwide

Inventor Zhang Jie (Sichuan Jiuzhang) releasing clinical data on chlorogenic acid for injection at the conferenceThe China BioMed Innovation and Investment Conference was held at the Suzhou Jinjihu In...

[View details]

Dr. Chen Xiaoguang, PI of anti-tumor mechanism study, was interviewed by people.cn

[On the afternoon of November 14, A reporter from people.cn made an exclusive interview with Dr. Chen Xiaoguang, a researcher of Institute of Materia Medica, Chinese Academy of Medical Sciences, at th...

[View details]